Manufacturer record
ACME Lafetech LLP: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by ACME Lafetech LLP (Himachal Pradesh) was declared Not of Standard Quality in July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ZC2R24003, Rabeprazole Sodium & Sustained Release Domperidone Capsules(Rabiet DSR) (exp Mar 2026). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium. Listed in the July 2025 alert.
Records by type
1 record linked to ACME Lafetech LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium & Sustained Release Domperidone Capsules(Rabiet DSR) | Batch ZC2R24003Mfg Apr 2024 · Exp Mar 2026 | The sample does not conform to the claim with respect to Assay of Rabeprazole SodiumAssay | DTL, JaipurState lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.